Debt-to-equity of Ultragenyx Pharmaceutical Inc. from 30 Sep 2014 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ultragenyx Pharmaceutical Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2014 to 31 Dec 2025.
  • Ultragenyx Pharmaceutical Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 2264%, a 457% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Ultragenyx Pharmaceutical Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 2264% +1858% +457% 31 Dec 2025
Q3 2025 844% +446% +112% 30 Sep 2025
Q2 2025 528% -15% -2.8% 30 Jun 2025
Q1 2025 405% -423% -51% 31 Mar 2025
Q4 2024 407% -320% -44% 31 Dec 2024
Q3 2024 398% -249% -39% 30 Sep 2024
Q2 2024 543% +142% +36% 30 Jun 2024
Q1 2024 828% +587% +243% 31 Mar 2024
Q4 2023 726% +571% +367% 31 Dec 2023
Q3 2023 647% +543% +522% 30 Sep 2023
Q2 2023 401% +329% +460% 30 Jun 2023
Q1 2023 241% +178% +284% 31 Mar 2023
Q4 2022 156% +98% +170% 31 Dec 2022
Q3 2022 104% +50% +91% 30 Sep 2022
Q2 2022 71% +12% +20% 30 Jun 2022
Q1 2022 63% -3.5% -5.2% 31 Mar 2022
Q4 2021 58% -21% -27% 31 Dec 2021
Q3 2021 54% -34% -39% 30 Sep 2021
Q2 2021 60% -10% -15% 30 Jun 2021
Q1 2021 66% +17% +33% 31 Mar 2021
Q4 2020 78% +49% +171% 31 Dec 2020
Q3 2020 89% +71% +415% 30 Sep 2020
Q2 2020 70% +54% +340% 30 Jun 2020
Q1 2020 50% +34% +226% 31 Mar 2020
Q4 2019 29% +14% +91% 31 Dec 2019
Q3 2019 17% +0.81% +4.9% 30 Sep 2019
Q2 2019 16% -1.2% -7.1% 30 Jun 2019
Q1 2019 15% -2.6% -14% 31 Mar 2019
Q4 2018 15% -3% -16% 31 Dec 2018
Q3 2018 16% +1.5% +10% 30 Sep 2018
Q2 2018 17% +3.5% +26% 30 Jun 2018
Q1 2018 18% +5.9% +50% 31 Mar 2018
Q4 2017 18% +7.5% +70% 31 Dec 2017
Q3 2017 15% +6.5% +78% 30 Sep 2017
Q2 2017 14% +7.4% +120% 30 Jun 2017
Q1 2017 12% +6% +104% 31 Mar 2017
Q4 2016 11% +5.4% +104% 31 Dec 2016
Q3 2016 8.3% +2.9% +54% 30 Sep 2016
Q2 2016 6.2% +0.15% +2.4% 30 Jun 2016
Q1 2016 5.8% +0.28% +5% 31 Mar 2016
Q4 2015 5.2% -0.63% -11% 31 Dec 2015
Q3 2015 5.4% -3.1% -36% 30 Sep 2015
Q2 2015 6% 30 Jun 2015
Q1 2015 5.6% 31 Mar 2015
Q4 2014 5.8% 31 Dec 2014
Q3 2014 8.5% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.